零售業(yè)現(xiàn)狀分析(編輯修改稿)
2024-11-05 04:14 本頁面
【文章內(nèi)容簡介】 。 5 第2章 我國醫(yī)藥零售行業(yè)存在的問題 7 醫(yī)藥零售行業(yè)連鎖經(jīng)營不規(guī)范 7 價格惡性競爭嚴重 7 經(jīng)營散亂，未形成規(guī)模競爭力 8 第3章 我國醫(yī)藥零售行業(yè)的發(fā)展對策 9 進一步加大各地藥品監(jiān)督管理局的監(jiān)管力度 9 努力提高連鎖經(jīng)營的管理水平 9 積極開展特色化、多元化經(jīng)營 10 擴大連鎖經(jīng)營的規(guī)模 10 結論 11 參考文獻 12 致謝 錯誤！未定義書簽。0 沈陽藥科大學本科畢業(yè)論文摘要摘要隨著我國市場經(jīng)濟的發(fā)展，醫(yī)藥零售業(yè)在國民經(jīng)濟中扮演著愈來愈重要的角色，它的多種經(jīng)營模式及多元化的發(fā)展為零售行業(yè)注入了更多的活力。但同時，醫(yī)藥零售企業(yè)一方面面臨加入WTO的挑戰(zhàn)，面臨網(wǎng)絡經(jīng)濟的發(fā)展機遇，面臨具有雄厚資金實力、超前經(jīng)營理念、高超管理水平、現(xiàn)代化經(jīng)營手段的跨國商業(yè)集團的沖擊。另一方面，還將面臨國家GSP認證的實施，藥品降價的沖擊的壓力。因此，分析我國醫(yī)藥零售業(yè)的現(xiàn)狀，探索其實踐發(fā)展策略，具有重要的現(xiàn)實意義。本文從兩方面介紹了醫(yī)藥零售業(yè)的現(xiàn)狀，即我國藥品零售企業(yè)現(xiàn)有的經(jīng)營模式和醫(yī)藥零售行業(yè)的特點。分析了現(xiàn)階段存在的主要問題，如，醫(yī)藥零售行業(yè)連鎖經(jīng)營不規(guī)范；價格惡性競爭嚴重；經(jīng)營散亂，未形成規(guī)模競爭力等。提出了解決問題的對策，如，進一步加大各地藥品監(jiān)督管理局的監(jiān)管力度；努力提高連鎖經(jīng)營的管理水平；積極開展特色化、多元化經(jīng)營；擴大連鎖經(jīng)營的規(guī)模等。希望為我國的醫(yī)藥零售業(yè)發(fā)展提供參考。關鍵詞： 醫(yī)藥零售業(yè)；連鎖經(jīng)營；發(fā)展對策 沈陽藥科大學本科畢業(yè)論文英文摘要AbstractAs China39。s market economic development, medicine retail industry in the national economy plays an increasingly important role, The modes of management and diversified development for the retail industry has injected more the same time, the medicine retail enterprises, facing the challenges of WTO accession, the network is facing economic development opportunities, faced with strong capital strength, advanced management concepts and excellent management level, modern business means transnational business groups other hand, the country will be faced with the implementation of the GSP certification, the impact of pharmaceutical price , the analysis of the status of retail medicine, and to explore its practice of the development strategy is of great practical this paper, two aspects of the status of retail medicine, Drugs that our existing retail enterprise business model and the medical characteristics of the retail of the present stage of the main problems, such as medicine retail industry chain operations are not standardized。Serious vicious price petition。Scattered business, not largescale petitive measures to address those problems, such as further intensify throughout the State Drug Administration regulation。efforts to improve the management chain。active features, diversified chain of hope for the medicine retail development ： Medicine retail trade；Chainlike management；Development countermeasure 沈陽藥科大學本科畢業(yè)論文引言引言立題背景：目前醫(yī)藥經(jīng)濟正處在轉(zhuǎn)型經(jīng)濟的大環(huán)境之中。一方面，隨著我國加入WTO，經(jīng)濟全球化程度在快速提高，國際資本和先進技術將快速對國內(nèi)市場進行滲透，并產(chǎn)生一系列的“應激反應”和“連鎖反應”[1]。另一方面，以社會保障體制改革為核心的三項改革已在我國全面推開，一向受到良好行政保護的我國醫(yī)藥市場，快速地轉(zhuǎn)入市場競爭調(diào)節(jié)狀態(tài)。在這種快速轉(zhuǎn)軌和轉(zhuǎn)型過程中，醫(yī)藥市場的資源規(guī)劃問題、醫(yī)藥企業(yè)的體制問題、營銷戰(zhàn)略問題等等紛至沓來。這些問題，最突出體現(xiàn)在當前的醫(yī)藥零售業(yè)上。所以，分析我國醫(yī)藥零售業(yè)的現(xiàn)狀
化學相關推薦
鄂ICP備17016276號-1